Covered recipient · General Payments record
APRIL D PRICE
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,390.11
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $603.83 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $132.15 | 15 |
| Lilly USA, LLC | $84.78 | 4 |
| UCB, Inc. | $60.68 | 2 |
| EMD Serono, Inc. | $51.28 | 2 |
| Biogen, Inc. | $48.00 | 2 |
| PFIZER INC. | $41.18 | 2 |
| Integra LifeSciences Corporation | $35.19 | 1 |
| ARGENX US, INC. | $25.73 | 1 |
| Lundbeck LLC | $24.12 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.89 | 1 |
| Kyowa Kirin, Inc. | $20.76 | 1 |
| Medtronic, Inc. | $20.67 | 1 |
| Teva Pharmaceuticals USA, Inc. | $18.30 | 1 |
| Neurelis, Inc. | $17.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.91 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108038802 | CMS |
| ABBVIE INC. | $8.38 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108038804 | CMS |
| ABBVIE INC. | $1.75 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108038806 | CMS |
| ABBVIE INC. | $3.64 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108038808 | CMS |
| ABBVIE INC. | $13.02 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108038810 | CMS |
| ABBVIE INC. | $23.50 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108038812 | CMS |
| ABBVIE INC. | $2.33 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108038814 | CMS |
| ABBVIE INC. | $3.11 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108038816 | CMS |
| ABBVIE INC. | $9.21 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108038818 | CMS |
| ABBVIE INC. | $10.19 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108038820 | CMS |
| ABBVIE INC. | $7.28 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108038822 | CMS |
| ABBVIE INC. | $8.46 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108038824 | CMS |
| ABBVIE INC. | $2.15 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108038826 | CMS |
| ABBVIE INC. | $7.39 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108038828 | CMS |
| ABBVIE INC. | $11.83 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108038830 | CMS |
| ARGENX US, INC. | $25.73 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142149114 | CMS |
| Biogen, Inc. | $22.85 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104866912 | CMS |
| Biogen, Inc. | $25.15 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104857714 | CMS |
| EMD Serono, Inc. | $27.87 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120237126 | CMS |
| EMD Serono, Inc. | $23.41 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120237128 | CMS |
| Integra LifeSciences Corporation | $35.19 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140142783 | CMS |
| Kyowa Kirin, Inc. | $20.76 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127046851 | CMS |
| Lilly USA, LLC | $22.46 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135517376 | CMS |
| Lilly USA, LLC | $19.27 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135476786 | CMS |
| Lilly USA, LLC | $21.30 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135517374 | CMS |
| Lilly USA, LLC | $21.75 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135537835 | CMS |
| Lundbeck LLC | $24.12 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146077536 | CMS |
| Medtronic, Inc. | $20.67 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116985733 | CMS |
| Neurelis, Inc. | $17.10 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145669286 | CMS |
| PFIZER INC. | $17.82 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131106216 | CMS |
| PFIZER INC. | $23.36 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130880498 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.89 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137810024 | CMS |
| Teva Pharmaceuticals USA, Inc. | $18.30 | 12/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151610348 | CMS |
| UCB, Inc. | $25.16 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143110474 | CMS |
| UCB, Inc. | $35.52 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143110476 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.